Premier Research, a clinical research company, has named Cassandra Matney, MD as its new senior medical director, it was reported on Monday.
Matney has experience in both solid and haemato-oncology tumours. Her therapeutic work in haematology and oncology includes prostate cancer, acute myeloid leukaemia, multiple myeloma, myeloproliferative neoplasms, myelodysplastic syndromes, B-cell malignancies, urothelial/bladder cancer, gastric/gastroesophageal cancer, and graft versus host disease.
Most recently, Matney managed medical affairs positions at Astellas Pharmaceuticals Global Development Inc, Janssen Oncology (a pharmaceutical company of Johnson & Johnson), and Incyte Corporation. She has also served as CRO and has site experience working at both Covance and academic centre Meharry Medical College, respectively.
Matney holds a medical degree at the Universidad Autonoma de Guadalajara and New York Medical College, and a Bachelor of Science degree from Illinois State University. She is certified by the Educational Commission for Foreign Medical Graduates.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer